Systemic chemotherapy of murine bladder cancer
- 30 April 1984
- Vol. 23 (4) , 129-134
- https://doi.org/10.1016/s0090-4295(84)80083-7
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Methotrexate: An active drug in bladder cancerCancer, 1981
- Clinical trial of VP 16–213 (NSC 141540) I.V. Twice weekly in advanced neoplastic disease a study by the cancer and leukemia group BCancer, 1980
- Chemotherapy of small cell carcinoma of the lung with V. P. 16–213Cancer, 1978
- The Treatment of Advanced Bladder Cancer with MethotrexateBritish Journal of Urology, 1977
- Cytofluorometric studies on the action of podophyllotoxin and epipodophyllotoxins (VM-26, VP-16-213) on the cell cycle traverse of human lymphoblasts.The Journal of cell biology, 1975
- A clinical trial of the oral form of 4′-demethyl-epipodophyllotoxin-β-D ethylidene glucoside (NSC 141540) VP 16–213Cancer, 1975
- Epipodophyllotoxin VP 16213 in Treatment of Acute Leukaemia--Haematosarcoma and Solid TumoursBMJ, 1973
- Activity of a new glycosidic lignan derivative (VP 16-213) related to podophyllotoxin in experimental tumorsPublished by Elsevier ,1973